What is a 7 3 regimen?

What is a 7 3 regimen?

The name “7+3” comes from the duration of chemotherapy course, which consists of 7 days of standard-dose cytarabine, and 3 days of an anthracycline antibiotic or an anthracenedione, most often daunorubicin (can be substituted for doxorubicin or idarubicin or mitoxantrone).

How long is induction therapy for AML?

Standard remission induction therapy currently consists of 3 days of an anthracycline and 7 days of cytarabine. Following induction, patients typically require 2-3 weeks for bone marrow blood cell production to recover.

What is induction phase of chemotherapy?

Chemotherapy. Treatment of ALL is usually urgent and needs to be given within days, and sometimes the same day, as the diagnosis is made. The first phase of treatment, called induction chemotherapy, requires that patients remain in the hospital for approximately four weeks.

What are the current treatment options for AML?

Treatment of AML depends upon your specific subtype of AML. For example, people with a certain type of AML, called “acute promyelocytic leukemia,” may be treated with other (non-chemotherapy) medications . Treatment also depends on your age and the presence of any other active medical problems.

What is 7+3 chemo?

“7+3” in the context of chemotherapy is an acronym for a chemotherapy regimen that is most often used today (as of 2014) as first-line induction therapy (to induce remission) in acute myelogenous leukemia, excluding the acute promyelocytic leukemia form, which is better treated with ATRA and/or arsenic trioxide and requires less chemotherapy (if

What is induction chemotherapy?

Induction chemotherapy. Induction chemotherapy is the first line treatment of cancer with a chemotherapeutic drug. The goal of induction chemotherapy is to cure the cancer.

What are treatments work on acute myeloid leukemia (AML)?

Treatment overview. Intensive chemotherapy. Chemotherapy by phase. Side effects of chemotherapy. Targeted therapy. Acute promyelocytic leukemia (APL) treatment. Radiation therapy. Getting care for symptoms and side effects. Refractory AML. Remission and the chance of recurrence.